Cargando…

Ferroptosis in Ovarian Cancer: A Novel Therapeutic Strategy

Ovarian cancer (OVCA) is one of the most lethal malignancies with a five-year relative survival below 50% by virtue of its high recurrence rate and inadequate early detection methods. For OVCA patients, modern approaches include debulking surgery, chemotherapies, angiogenesis inhibitors, poly ADP-ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lanyu, Qiu, Cheng, Hou, Min, Wang, Xinyu, Huang, Changzhen, Zou, Jialin, Liu, Tianyi, Qu, Jinfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117419/ https://www.ncbi.nlm.nih.gov/pubmed/33996593 http://dx.doi.org/10.3389/fonc.2021.665945

Ejemplares similares

Pyroptosis: A Developing Foreland of Ovarian Cancer Treatment
por: Liu, Tianyi, et al.
Publicado: (2022)

Novel Therapeutic Savior for Osteosarcoma: The Endorsement of Ferroptosis
por: Qiu, Cheng, et al.
Publicado: (2022)

Ferroptosis: A novel therapeutic strategy and mechanism of action in glioma
por: Zhang, Gaosen, et al.
Publicado: (2022)

Novel Therapeutic Strategies for Ovarian Cancer Stem Cells
por: Terraneo, Nastassja, et al.
Publicado: (2020)

Ferroptosis: A New Strategy for Cancer Therapy
por: Chen, Yu, et al.
Publicado: (2022)

From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells
por: Grignano, Eric, et al.
Publicado: (2020)

Ferroptosis and triple-negative breast cancer: Potential therapeutic targets
por: Xu, Na, et al.
Publicado: (2022)

Wnt/β-Catenin Inhibition by CWP232291 as a Novel Therapeutic Strategy in Ovarian Cancer
por: Wang, Wenyu, et al.
Publicado: (2022)

Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer
por: Sun, Jiale, et al.
Publicado: (2021)

Ferroptosis-Related Long Noncoding RNAs as Prognostic Biomarkers for Ovarian Cancer
por: Wang, Kaili, et al.
Publicado: (2022)

Editorial: Emerging strategies for cancer therapy targeting ferroptosis
por: Li, Manshan, et al.
Publicado: (2023)

Insights Into Ferroptosis, a Novel Target for the Therapy of Cancer
por: Wang, Hong-Tao, et al.
Publicado: (2022)

Lipid metabolism in ferroptosis and ferroptosis-based cancer therapy
por: Sun, Yonghao, et al.
Publicado: (2022)

Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells
por: Battaglia, Anna Martina, et al.
Publicado: (2022)

TIMELESS Promotes Tumor Progression by Enhancing Macrophages Recruitment in Ovarian Cancer
por: Xing, Xin, et al.
Publicado: (2021)

Current Status and Prospects of Research on Ischemia-Reperfusion Injury and Ferroptosis
por: Hou, Lin, et al.
Publicado: (2022)

Ferroptosis in Lung Cancer: From Molecular Mechanisms to Prognostic and Therapeutic Opportunities
por: Tabnak, Peyman, et al.
Publicado: (2021)

A Novel Ferroptosis-Related 4-Gene Prognostic Signature for Cholangiocarcinoma and Photodynamic Therapy
por: Zhang, Zi-jian, et al.
Publicado: (2021)

Regulation of iron metabolism and ferroptosis in cancer stem cells
por: Wang, Hailiang, et al.
Publicado: (2023)

Emerging roles of ferroptosis in glioma
por: Shi, Jiaqi, et al.
Publicado: (2022)

Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
por: He, Jiangnan, et al.
Publicado: (2021)

Designer Exosomes for Targeted Delivery of a Novel Therapeutic Cargo to Enhance Sorafenib-Mediated Ferroptosis in Hepatocellular Carcinoma
por: Li, Xiaoju, et al.
Publicado: (2022)

Ferroptosis in Cancer Treatment: Another Way to Rome
por: Wu, Yinan, et al.
Publicado: (2020)

A ferroptosis-related gene signature associated with immune landscape and therapeutic response in osteosarcoma
por: Wang, Xinxing, et al.
Publicado: (2022)

Lipid droplets and ferroptosis as new players in brain cancer glioblastoma progression and therapeutic resistance
por: Bezawork-Geleta, Ayenachew, et al.
Publicado: (2022)

The role of ferroptosis in prostate cancer: a novel therapeutic strategy
por: Wang, Yue, et al.
Publicado: (2022)

A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer
por: Yang, Libo, et al.
Publicado: (2021)

A novel 25-ferroptosis-related gene signature for the prognosis of gliomas
por: Peng, Xiaojiang, et al.
Publicado: (2023)

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
por: Feng, Xiaojie, et al.
Publicado: (2019)

Peptides for diagnosis and treatment of ovarian cancer
por: Guo, Ling, et al.
Publicado: (2023)

Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research
por: Clark, James, et al.
Publicado: (2022)

Ferroptosis: Biochemistry and Biology in Cancers
por: Shi, Zhiyuan, et al.
Publicado: (2021)

Ferroptosis in hematological malignant tumors
por: Liu, Yong, et al.
Publicado: (2023)

Ferroptosis-based drug delivery system as a new therapeutic opportunity for brain tumors
por: Yao, Yansheng, et al.
Publicado: (2023)

Ubiquitin-Like Modifier Activating Enzyme 1 as a Novel Diagnostic and Prognostic Indicator That Correlates With Ferroptosis and the Malignant Phenotypes of Liver Cancer Cells
por: Shan, Yiru, et al.
Publicado: (2020)

A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer
por: Nie, Jianhua, et al.
Publicado: (2021)

Autophagy-dependent ferroptosis as a potential treatment for glioblastoma
por: Xie, Yangchun, et al.
Publicado: (2023)

Crosstalk between microwave ablation and ferroptosis: The next hot topic?
por: Yu, Lu, et al.
Publicado: (2023)

Characterization and role exploration of ferroptosis-related genes in osteoarthritis
por: Wang, Xinyu, et al.
Publicado: (2023)

Identification of Novel Prognostic Risk Signatures of Soft Tissue Sarcoma Based on Ferroptosis-Related Genes
por: Huang, Wenjing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gjg7vtkdas6fg6v2e2ffafk6jd